近端胃癌NO5和NO6淋巴结转移的相关危险因素研究

来源 :第十三届全国胃癌学术会议 | 被引量 : 0次 | 上传用户:sms888
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  目的 分析并探讨近端胃癌(PGC)患者中NO.5 和NO.6 淋巴结转移情况及相关危险因素.方法 回顾性分析上海交通大学医学院附属瑞金医院于2014.09.30 至2017.12.21 收治的PGC患者的临床资料,排除术前接受新辅助放化疗的患者后纳入292 例数据.
其他文献
Objective To investigate the short-term efficacies of robotic spleen-preserving splenic hilar lymphadenectomy(RSPSHL)and laparoscopic spleen-preserving splenic hilar lymphadenectomy(LSPSHL)for advance
Objective Robotic systems recently have been introduced to overcome technical limitations of conventional laparoscopic gastrectomy,especially for complex procedures.
Objective Robotic-assisted gastrectomy(RAG)has been rapidly adopted for gastric cancer(GC)treatment.However,whether RAG provides any significant outcome/cost advantages over laparoscopy-assisted gastr
Objective Robotic gastrectomy(RG)is a new surgical method alternative for gastric cancer.However,few studies have evaluated the outcomes of RG for advanced gastric cancer(AGC).
Objective Robot-assisted gastrectomy(RAG)is a technically feasible and safe procedure in treating gastric cancer(GC).However,concern about oncological radicality and long-term outcomes has limited the
Objective Comparison of robotic and laparoscopic assisted gastrectomy in advanced gastric cancer: updated short-and long-term results Emerging evidence has demonstrated laparoscopic-assisted gastrecto
Objective The objective of the study is to present the clockwise and modularized lymphadenectomy model of laparoscopic gastrectomy for gastric cancer patients,which is based on our ten-year clinical p
Objective The 8th TNM classification for gastric cancer separates the final pathological stage of pN3 into pN3a and pN3b.The cutoff that separates pN3a/pN3b is defined as 15 metastatic lymph nodes,but
目的 目的 比较3D 腹腔镜根治性全胃切除术与传统2D 腹腔镜根治性全胃切除术对区域淋巴结清扫及并发症的影响。方法 选择2015 年3 月至2017 年11 月在福建省肿瘤医院行腹腔镜根治性全胃切除的268 例患者的临床病理资料。
目的 胃窦、胃体癌中第2 组淋巴结属于第3 站淋巴结,胃癌手术淋巴结清扫中常不受重视。笔者术中发现多数胃窦、胃体癌患者伴有第2 组淋巴结肿大,遂进行清扫,对术后病理结果进行统计分析,探讨胃窦、胃体癌患者第2 组淋巴结的转移发生率及其影响因素。